2
2
2
2
2
2
1
1
2015
2012
Company (7)University (4)
1 - 7 of 7
Sort by
Patent
Publication NumberCN 102947710 BFiling StatusIssued PatentAvailabilityUnknownFiling Date2011-01-28Publication Date2015-01-14
The present disclosure relates general to devices, systems, and methods of using such devices in creating and handling hanging drops of fluid. The present disclosure also relates to cell culture devices, methods and/or systems of using such devices as well as the use of cell culture devices, for example, for research and high throughput screening.
Patent
Publication NumberUS 8906685Filing StatusIssued PatentAvailabilityUnknownFiling Date2011-01-28Publication Date2014-12-09
The present disclosure relates general to devices, systems, and methods of using such devices in creating and handling hanging drops of fluid. The present disclosure also relates to cell culture devices, methods and/or systems of using such devices as well as the use of cell culture devices, for example, for research and high throughput screening.
Patent
Publication NumberUS 20140179561Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2014-02-25Publication Date2014-06-26
The present disclosure relates general to devices, systems, and methods of using such devices in creating and handling hanging drops of fluid. The present disclosure also relates to cell culture devices, methods and/or systems of using such devices as well as the use of cell culture devices, for example, for research and high throughput screening.
Research Grant
Project Number3R41CA165463-01A1S1Funding AgencyNational Institutes of HealthEffective Date2013-07-01Expiration Date2013-11-30Funding Amount$34,628
DESCRIPTION (provided by applicant): Prostate cancer is the most common non-skin cancer in United States men. Despite recent advances, prostate cancer mortality still remains high due to the emergence of therapy-resistant cancer cells that metastasize. This lack of effective therapies against metastatic cancer exists, at least in part, because of lack of drug screening platforms that address the unique nature of metastastatic prostate cancer cells and their microenvironment. Recently, our col…
SEC Filing
Accession Number0001551050-13-000001Form TypeDAcceptance Date2013-02-05
Sold $1,465,000 of Equity, Option to Acquire, and Security to be Acquired
Patent
Publication NumberEP 2529238 A2Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2011-01-28Publication Date2012-12-05
Research Grant
Project Number1R41CA165463-01A1Funding AgencyNational Institutes of HealthEffective Date2012-06-04Expiration Date2013-11-30Funding Amount$199,134
DESCRIPTION (provided by applicant): Prostate cancer is the most common non-skin cancer in United States men. Despite recent advances, prostate cancer mortality still remains high due to the emergence of therapy-resistant cancer cells that metastasize. This lack of effective therapies against metastatic cancer exists, at least in part, because of lack of drug screening platforms that address the unique nature of metastastatic prostate cancer cells and their microenvironment. Recently, our col…
We found 7 documents that match your Search
Research Grants: 2
Patents: 4
SEC Filings: 1

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in